Abstract
Synovial sarcoma comprises approximately 10
Synovial sarcoma comprises approximately 10
N. L. Cadman, E. H. Soule, and P. J. Kelly, “Synovial sarcoma: an analysis of 134 tumors,” Cancer, vol. 18, no. 5, pp. 613–627, 1965.
View at: Publisher Site | Google ScholarS. Singer, E. H. Baldini, G. D. Demetri, J. A. Fletcher, and J. M. Corson, “Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival,” Journal of Clinical Oncology, vol. 14, no. 4, pp. 1201–1208, 1996.
View at: Google ScholarJ. R. Mullen and G. Zagars, “Synovial sarcoma outcome following conservation surgery and radiotherapy,” Radiotherapy and Oncology, vol. 33, no. 1, pp. 23–30, 1994.
View at: Publisher Site | Google ScholarC. A. Griffin and B. S. Emanuel, “Translocation (X;18) in a synovial sarcoma,” Cancer Genetics and Cytogenetics, vol. 26, no. 1, pp. 181–183, 1987.
View at: Publisher Site | Google ScholarH. M. Hazelbag, K. Szuhai, H. J. Tanke, C. Rosenberg, and P. C. W. Hogendoorn, “Primary synovial sarcoma of the heart: a cytogenic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype,” Modern Pathology, vol. 17, no. 11, pp. 1434–1439, 2004.
View at: Publisher Site | Google ScholarV. Iyengar, A. S. Lineberger, S. Kerman, and N. A. Burton, “Synovial sarcoma of the heart: correlation with cytogenetic findings,” Archives of Pathology and Laboratory Medicine, vol. 119, no. 11, pp. 1080–1082, 1995.
View at: Google ScholarC. M. Karn, M. A. Socinski, J. A. Fletcher, J. M. Corson, and J. E. Craighead, “Cardiac synovial sarcoma with translocation (X;18) associated with asbestos exposure,” Cancer, vol. 73, no. 1, pp. 74–78, 1994.
View at: Publisher Site | Google ScholarT. T. McGilbray and T. K. Schulz, “Primary cardiac synovial sarcoma,” The Lancet Oncology, vol. 4, no. 5, p. 283, 2003.
View at: Publisher Site | Google ScholarN. Al-Rajhi, S. Husain, R. Coupland, C. McNamee, and N. Jha, “Primary pericardial synovial sarcoma: a case report and literature review,” Journal of Surgical Oncology, vol. 70, no. 3, pp. 194–198, 1999.
View at: Publisher Site | Google ScholarS. Oizumi, K. Igarashi, and T. Takenaka et al., “Primary pericardial synovial sarcoma with detection of the chimeric transcript SYT-SSX,” Japanese Circulation Journal, vol. 63, no. 4, pp. 330–332, 1999.
View at: Publisher Site | Google ScholarP. Hummel, G. C. H. Yang, and A. Kumar et al., “PNET-like features of synovial sarcoma of the lung: a pitfall in the cytologic diagnosis of soft-tissue tumors,” Diagnostic Cytopathology, vol. 24, no. 4, pp. 283–288, 2001.
View at: Publisher Site | Google ScholarS. H. Sassi, N. Zargouni, M. S. Dakhlia, K. Mrad, M. Cammoun, and K. Ben Romdhane, “Primary synovial sarcoma of the heart. A clinicopathologic study of one case and review of the literature,” Pathologica, vol. 96, no. 1, pp. 29–34, 2004.
View at: Google ScholarA. A. Sandberg and J. A. Bridge, “Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma,” Cancer Genetics and Cytogenetics, vol. 133, no. 1, pp. 1–23, 2002.
View at: Publisher Site | Google ScholarA. Kawai, J. Woodruff, J. H. Healey, M. F. Brennan, C. R. Antonescu, and M. Ladanyi, “SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma,” New England Journal of Medicine, vol. 338, no. 3, pp. 153–160, 1998.
View at: Publisher Site | Google ScholarD. Brett, S. Whitehouse, P. Antonson, J. Shipley, C. Cooper, and G. Goodwin, “The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies,” Human Molecular Genetics, vol. 6, no. 9, pp. 1559–1564, 1997.
View at: Publisher Site | Google ScholarM. Nagai, S. Tanaka, and M. Tsuda et al., “Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3843–3848, 2001.
View at: Publisher Site | Google ScholarSarcoma Meta-Analysis Collaboration, “Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data,” The Lancet, vol. 350, no. 9092, pp. 1647–1654, 1997.
View at: Publisher Site | Google ScholarK. O'Byrne and W. P. Steward, “The role of chemotherapy in the treatment of adult soft tissue sarcomas,” Oncology, vol. 56, no. 1, pp. 13–23, 1999.
View at: Publisher Site | Google ScholarY. Sato, Y. Nabeta, and T. Tsukahara et al., “Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A patients with synovial sarcoma,” Journal of Immunology, vol. 169, no. 3, pp. 1611–1618, 2002.
View at: Google ScholarS. Kawaguchi, T. Wada, and K. Ida et al., “Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma,” Journal of Translational Medicine, vol. 3, no. 1, p. 1, 2005.
View at: Publisher Site | Google Scholar